| Serial Number | 86096198 |
| Word Mark | CANNABICS |
| Filing Date | Sunday, October 20, 2013 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Sunday, January 22, 2023 |
| Registration Number | 4967078 |
| Registration Date | Tuesday, May 31, 2016 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 15, 2016 |
| Goods and Services | Acetaminophen; Anti-cancer preparations; Antiallergic medicines; Biological preparations for the treatment of cancer; Biological preparations for the treatment of PTSD; Blood containers for veterinary and human medical and clinical use sold filled with a platelet additive solution; Blood for medical purposes; Blood plasma; Bowel evacuant preparations; Chemically treated papers for use in the detection of fecal occult blood; Clinical medical reagents for processing human whole blood and its components for use in blood transfusions stored in bags, bottles, syringes and other such containers used to store such substances in the medical field; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for Slow release that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Flower essences for medical purposes for the treatment of pain; Gastrointestinal cleaning agents; Glaucoma agents; Herb teas for medicinal purposes; Herbal teas for medicinal purposes; Herbs for medicinal purposes; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Medicaments for promoting recovery from tendon and muscle injuries and disorders and sports related injuries; Medicaments for cancer; Medicinal creams for skin care; Medicinal drinks; Medicinal hair growth preparations; Medicinal herb extracts; Medicinal herbal extracts for medical purposes; Medicinal herbal preparations; Medicinal herbs; Medicinal herbs in dried or preserved form; Medicinal infusions for treating Pain; Medicinal oils; Medicinal preparations for stimulating hair growth; Medicinal preparations for the mouth and as sprays; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal preparations for Pain; Medicinal radix glycyrrhizae; Medicinal roots; Medicinal tea; Medicinal tea used for the treatment of Pain; Medicines for dental purposes; Medicines for the treatment of gastrointestinal diseases; Molecular complex for the delivery of non-radical oxygen for medicinal, surgical, therapeutic or veterinary purposes; Natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; Pain relief medication; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Platelet additive solution for medical and clinical use in storing blood components; Preparation for the relief of pain; Preparations for the treatment of asthma; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Processed bee pollen for medicinal or therapeutic purposes; Processed cactus for medicinal or therapeutic purposes; Propolis for medicinal or therapeutic purposes; Radioactive substances for use in nuclear medicine; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Sea water for medicinal bathing; Solutions for medical and clinical use in storing and treating cells, blood and blood components; Sugar replacement for medicinal or therapeutic purposes; Sulphonamides as medicines; Sweets for medicinal purposes; Test strips for measuring blood glucose levels; Transdermal patches featuring botanical substances; Veterinary preparations, namely, pain relief medication |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Sunday, January 22, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, November 11, 2008 |
| First Use In Commerce Date | Tuesday, November 11, 2008 |
| Party Name | CANNABICS PHARMACEUTICALS INC. |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 03 - Corporation |
| Address | LAS VEGAS, NV 89108 |
| Party Name | Cannabics Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Brooklyn, NY 11213 |
| Party Name | Cannabics Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Brooklyn, NY 11213 |
| Party Name | Cannabics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Brooklyn, NY 11213 |
| Event Date | Event Description |
| Tuesday, January 24, 2023 | NOTICE OF CANCELLATION SEC. 8 EMAILED |
| Sunday, January 22, 2023 | CANCELLED SEC. 8 (6-YR) |
| Wednesday, December 1, 2021 | OFFICE ACTION ISSUED POU1 |
| Monday, November 29, 2021 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Wednesday, November 17, 2021 | TEAS SECTION 8 & 15 RECEIVED |
| Monday, May 31, 2021 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Wednesday, March 6, 2019 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Tuesday, February 26, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, February 26, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, May 31, 2016 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, May 4, 2016 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| Wednesday, May 4, 2016 | ASSIGNED TO PETITION STAFF |
| Monday, April 18, 2016 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Tuesday, March 15, 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 15, 2016 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 24, 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, February 11, 2016 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Thursday, February 4, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, January 12, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 12, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, January 6, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, July 16, 2015 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, July 16, 2015 | NON-FINAL ACTION E-MAILED |
| Thursday, July 16, 2015 | NON-FINAL ACTION WRITTEN |
| Monday, June 22, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, June 22, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, June 15, 2015 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, June 15, 2015 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, January 27, 2015 | NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED |
| Tuesday, January 27, 2015 | NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED |
| Tuesday, January 27, 2015 | REPORT UNRESPONSIVE AMENDMENT - COMPLETED |
| Tuesday, January 6, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 6, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 6, 2015 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, September 26, 2014 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, September 26, 2014 | NON-FINAL ACTION E-MAILED |
| Friday, September 26, 2014 | NON-FINAL ACTION WRITTEN |
| Thursday, September 4, 2014 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, September 4, 2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, August 27, 2014 | ASSIGNED TO LIE |
| Friday, August 22, 2014 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, August 22, 2014 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, August 22, 2014 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Friday, August 22, 2014 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Wednesday, August 20, 2014 | NOTICE OF REVIVAL - E-MAILED |
| Wednesday, August 20, 2014 | PETITION TO REVIVE-GRANTED |
| Wednesday, August 20, 2014 | TEAS PETITION TO REVIVE RECEIVED |
| Monday, June 30, 2014 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Monday, June 30, 2014 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Monday, November 18, 2013 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, November 18, 2013 | NON-FINAL ACTION E-MAILED |
| Monday, November 18, 2013 | NON-FINAL ACTION WRITTEN |
| Monday, November 4, 2013 | ASSIGNED TO EXAMINER |
| Friday, October 25, 2013 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, October 23, 2013 | NEW APPLICATION ENTERED |